From Professor Andrew Hill, La Trobe University, Melbourne:
We are proud to share this paper published today from our groups in Melbourne (and collaboration with Inga Zerr in Germany) on identifying potential blood-based biomarkers for CJD. We greatly appreciate the support of the CJDSGN Memorial Awards in memory of Lorraine Seabrook, Adrian Chesterton, Norma Crawley, and Danilo Banzon which helped fund this work. The paper is freely available below.
We have an open IND. What comes next?
www.cureffi.org
FDA has cleared a new drug to advance to first-in-human studies in prion disease patients. Here's what this means.
Team hits milestone toward prion disease treatment — Harvard Gazette
news.harvard.edu
Patient-scientist and husband are among the researchers who developed a promising gene-editing treatment for the rare, fatal condition.
© 2025 CJD Support Group Network Australia.
The CJDSGN acknowledges the funding provided by the Department of Health
that assists towards the cost of this website.
Disclaimer Privacy Policy
